Alterity Therapeutics (ATHE) Capital Expenditures (2016 - 2019)
Alterity Therapeutics (ATHE) posted quarterly Capital Expenditures of $5123.2 for Q4 2019, up 318.19% year-over-year from $1225.1 in Q4 2018, and up 318.19% quarter-over-quarter from -$2348.0 in Q4 2018.
Alterity Therapeutics (ATHE) Capital Expenditures (2016 - 2019) Analysis & Trends
Alterity Therapeutics' Capital Expenditures history runs 4 years deep, the most recent figure standing at $5123.2 for Q4 2019.
- In Q4 2019, Capital Expenditures rose 318.19% year-over-year to $5123.2; the TTM figure through Dec 2019 stood at -$16414.6 (up 63.84% YoY), while the FY2024 annual figure was -$5722.0, changed N/A from the prior year.
- Capital Expenditures for Q4 2019 stood at $5123.2, up from -$2348.0 in the prior quarter.
- The five-year high for Capital Expenditures was $5123.2 in Q4 2019, with the low at -$16622.8 in Q4 2016.
- The 4-year median for Capital Expenditures is -$2457.5 (2017), against an average of -$4103.7.
- The sharpest annual moves came in 2018 and 2019: Capital Expenditures advanced 8.53% in 2018, then jumped 318.19% in 2019.
- Alterity Therapeutics' Capital Expenditures stood at -$16622.8 in 2016, then surged by 84.56% to -$2567.1 in 2017, then rose by 8.53% to -$2348.0 in 2018, then surged by 318.19% to $5123.2 in 2019.
- Business Quant data shows ATHE's Capital Expenditures at $5123.2 in Q4 2019, -$2348.0 in Q4 2018, and -$2567.1 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 5,123.23 |
| Dec 31, 2019 | 5,123.23 |
| Dec 31, 2018 | -2,348.04 |
| Dec 31, 2018 | -2,348.04 |
| Dec 31, 2017 | -2,567.05 |
| Dec 31, 2017 | -2,567.05 |
| Dec 31, 2016 | -16,622.76 |
| Dec 31, 2016 | -16,622.76 |